Loading…
← CockpitCompetitor Analysis › 601567.SS Ningbo Sanxing Medical Electric Co., Ltd. Class AOpen in the cockpit ↗

Ningbo Sanxing Medical Electric Co., Ltd. Class A601567.SSCompetitor analysis, valuation and peers

China · CNY·Information Technology›Electronic Equipment/Instruments

Chinese maker of smart electricity meters and power-grid metering equipment, despite the 'Medical' name.

Momentum laggard 11
Mkt cap
$2.66B
US dollars, full cap
Free float
39%
of shares outstanding
$/day
$26.7M
20-day average traded
Fwd P/E
15.8×
forward earnings
ROIC−WACC
-0.7 pp
WACC 5.1%
Hurdle
-10 pp
Req g minus delivered
Next earnings
168 days
23 Apr 2027
Close · CNYCN¥12.61
1D-1.6%
1W+9.2%
1M-8.3%
3M-24.4%
6M-37.1%
YTD-45.2%
1Y-45.2%
ATR %3.8%
52w lowhigh62.5% off high

What Ningbo Sanxing Medical Electric does

Chinese maker of smart electricity meters and power-grid metering equipment, despite the 'Medical' name.

Wins supply in periodic tenders from China's grid companies and in export contracts, so orders arrive in batches. Meters are installed once and replaced on a cycle of years, so income follows grid rollout and replacement programs.

Products and services

  • Smart electricity meters
  • Grid metering/monitoring equipment

Customers

  • State/provincial power grid companies
  • Utilities (export markets)

Where it sits in the supply chain

  • Power/grid equipment
  • Smart electricity meters

What could go right

  • Grid digitalisation, metering exports

What could go wrong

  • Utility capex cyclicality

Moat: narrow (customer qualification, installed base). Qualified supplier status with grid utilities in China and export markets.

Headquarters: Ningbo, China · Employees: 12,843

Named competitors

Ningbo Sanxing Medical Electric at a glance

Size Ningbo Sanxing Medical Electric (601567.SS) is a China Information Technology company (Electronic Equipment/Instruments) with a market value of $2.66B, the 971st largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥12.61 on 6 Nov 2026.

Performance Over six months the shares fell 37.1%, against -25.1% for the median peer and -16.4% for the China market (cap-weighted) — 7th lowest of 21 in its peer set.

Growth Revenue fell 10.6% over the last twelve months (peer median +11.0%); the operating margin is 2.8% (peer median 9.7%).

Valuation It trades at 15.8× forward earnings against a peer median of 21.6× (5th cheapest of 17).

Price implies For today's price to make sense, revenue must grow about 5% a year for seven years (Req g). Recent delivered growth is +15%, so the hurdle is -10 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 0.7 points below its cost of capital (5.1% WACC).

Next results Next results expected around 23 Apr 2027 (exchange calendar; dates can move).

Relative performance

608010011 May 202611 Aug 20266 Nov 2026Peer median 74601567.SS 62
Six months, rebased to 100: Ningbo Sanxing Medical Electric against the median of its 20 peers (local-currency closes).

Ningbo Sanxing Medical Electric financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥13.6BCN¥14.3BCN¥14.6BCN¥11.4BCN¥9.03B
Revenue growth—-2%+27%+26%—
Gross profitCN¥3.78BCN¥3.75BCN¥4.83BCN¥3.73BCN¥2.50B
EBITDAn/aCN¥1.78BCN¥2.97BCN¥2.09BCN¥1.35B
Net incomeCN¥446MCN¥1.27BCN¥2.26BCN¥1.90BCN¥948M
Free cash flowCN¥1.39BCN¥882MCN¥891MCN¥1.41BCN¥903M
Capital expenditureCN¥585MCN¥940MCN¥1.04BCN¥556MCN¥404M
Total debtCN¥3.91BCN¥6.66BCN¥4.95BCN¥4.23BCN¥2.33B

Quarterly statements and history in the cockpit →

Ningbo Sanxing Medical Electric competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%-25%0%+25%+50%-40%-20%0%+20%688785688167ONT6880014980VAIAS002335340630076330082760084800054760366277500021526886276728DBD688390002980601567.SS6-month return →1-month return →
Up and to the right = strong over both horizons. Ningbo Sanxing Medical Electric is the large dot.

Fundamentals: revenue growth against valuation

-25%0%+25%+50%0×100×200×300×6881676880014980VAIAS34063007633008276008487750688627688390601567.SSRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Ningbo Sanxing Medical Electric is the large dot.

Capital: growth delivered against growth the price implies

0%+10%+20%+30%+40%0%20%40%6880014980VAIAS00233534063007636008486036627750002152DBD688390601567.SSGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Ningbo Sanxing Medical Electric is the large dot.

Ningbo Sanxing Medical Electric competitors and peer comparison

Head to head with its named competitors (601567.SS vs 3393.HK vs 603556.SS vs 601222.SS)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Ningbo Sanxing Medical Electric 601567.SS$2.66B-37%-11%3%15.8×4.8%
Wasion 3393.HK$1.43B-59%+22%16%8.0×-11.3%
Hexing Electrical 603556.SS$1.61B-23%+6%9%14.2×0.1%
Jiangsu Linyang Energy 601222.SS$1.74B-6%+35%8%15.4×n/a
Landis+Gyr LAND.SW$2.01B+17%-22%25%21.5×-10.2%
Itron ITRI$4.32B+20%-4%14%14.5×9.2%

How Ningbo Sanxing Medical Electric compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Ningbo Sanxing Medical Electric against its 20 peers (data as of 6 Nov 2026)
Measure601567.SSPeer medianRank in peer set
1-month return-8.3%-11.6%9th highest of 21
6-month return-37.1%-25.1%7th lowest of 21
Distance from 52-week high-62.5%-49.9%5th lowest of 21
Revenue growth (TTM)-10.6%+11.0%2nd lowest of 21
Operating margin2.8%9.7%4th lowest of 21
Forward P/E15.8×21.6×5th cheapest of 17
Growth the price implies (Req g, 7 yrs)4.8%14.1%3rd least demanding of 14
Growth delivered (Del g)+15.1%+13.4%4th highest of 14
Hurdle (Req g minus delivered)-10.3 pp-1.5 pp3rd least demanding of 14
ROIC minus cost of capital-0.7 pp-1.5 pp10th highest of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Ningbo Sanxing Medical Electric 601567.SSChina$2.66B-37%-11%3%15.8×4.8%+15.1%
Shenzhen CSL Vacuum Science & Technology 688785.SSChina$2.62B-21%-2%18%n/an/an/a
Focuslight Technologies 688167.SSChina$2.71B-44%+22%-9%284.8×n/an/a
Oxford Nanopore Technologies ONT.LUnited Kingdom$2.71B+75%+15%-55%n/an/an/a
Suzhou HYC Technology 688001.SSChina$2.59B-31%+19%6%61.1×37.6%+5.9%
Dexerials 4980.TJapan$2.55B-4%+5%35%13.8×15.0%+11.6%
Vaisala VAIAS.HEFinland$2.54B+22%+2%16%26.9×9.7%+9.5%
Kehua Data 002335.SZChina$2.81B-41%+5%5%31.4×16.7%+14.4%
GeniuS Electronic Optical 3406.TWTaiwan$2.81B+59%+16%20%20.1×5.9%+9.5%
Ginlong Technologies 300763.SZChina$2.98B-47%+4%11%19.2×10.0%+27.2%
Sineng Electric 300827.SZChina$2.35B-25%+29%12%24.7×n/an/a
Shanghai Lingang 600848.SSChina$3.00B-9%-26%15%19.4×12.9%+15.1%
Addsino 000547.SZChina$3.02B-49%-6%-54%n/an/an/a
Keli Sensing Technology (Ningbo) 603662.SSChina$2.28B-4%+24%19%51.6×24.7%+13.4%
Syntec Technology 7750.TWTaiwan$3.15B-46%+60%25%13.2×17.2%+24.3%
GRG Banking Equipment 002152.SZChina$3.26B-25%0%9%23.0×4.0%+13.5%
Shenzhen SEICHI Technologies 688627.SSChina$3.37B-24%+65%3%89.1×n/an/a
ULVAC 6728.TJapan$2.01B-34%+7%7%15.5×14.1%+8.0%
Diebold Nixdorf DBDUnited States$1.96B-25%+6%9%10.5×-2.0%-0.5%
Goodwe Technologies 688390.SSChina$1.93B-51%+53%5%17.1×17.4%+41.2%
Shenzhen Everbest Machinery Industry 002980.SZChina$1.90B-16%+64%23%n/an/an/a

Questions

Who are Ningbo Sanxing Medical Electric's main competitors?
Named competitors: Wasion Group (3393.HK), Hexing Electrical (603556.SS), Linyang Energy (601222.SS), Landis+Gyr (LAND.SW), Itron (ITRI). The cockpit's measured peer set (industry) also includes Shenzhen CSL Vacuum Science & Technology (688785.SS), Focuslight Technologies (688167.SS), Oxford Nanopore Technologies (ONT.L), Suzhou HYC Technology (688001.SS), Dexerials (4980.T), Vaisala (VAIAS.HE).
Is Ningbo Sanxing Medical Electric expensive compared with its peers?
On forward p/e it trades at 15.8× against a peer median of 21.6×, 5th cheapest of 17 in its peer set. For today's price to make sense, revenue must grow about 5% a year for seven years (Req g). Recent delivered growth is +15%, so the hurdle is -10 pp: the price already allows for a slowdown.
How has Ningbo Sanxing Medical Electric stock performed?
Over six months to 6 Nov 2026 the shares returned -37.1% against -25.1% for the median peer; over one year -45.2%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.